Blocklisting Interim Review

RNS Number:0318E
GW Pharmaceuticals PLC
13 October 2004



                        BLOCKLISTING SIX MONTHLY REVIEW


1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC


2. NAME OF SCHEME:

GW PHARMACEUTICALS APPROVED COMPANY SHARE OPTION SCHEME


3. PERIOD OF RETURN:

FROM: 1 APRIL 2004 TO: 12 OCTOBER 2004


4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

292,127 ORDINARY SHARES OF 0.1P EACH


5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

14,700 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

277,427 ORDINARY SHARES OF 0.1P EACH


7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

507,146 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003


PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.

110,965,581 ORDINARY SHARES OF 0.1P EACH





                        BLOCKLISTING SIX MONTHLY REVIEW


1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC


2. NAME OF SCHEME:

GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME


3. PERIOD OF RETURN:

FROM: 1 APRIL 2004 TO: 12 OCTOBER 2004


4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

1,369,825 ORDINARY SHARES OF 0.1P EACH


5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

266,633 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

1,103,192 ORDINARY SHARES OF 0.1P EACH


7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003


PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.

110,965,581 ORDINARY SHARES OF 0.1P EACH






                        BLOCKLISTING SIX MONTHLY REVIEW


1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC


2. NAME OF SCHEME:

GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001


3. PERIOD OF RETURN:

FROM: 21 JULY 2004 TO: 12 OCTOBER 2004


4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

N/A


5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

NIL

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

516,558 ORDINARY SHARES OF 0.1P EACH


7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004


PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.

110,965,581 ORDINARY SHARES OF 0.1P EACH





                        BLOCKLISTING SIX MONTHLY REVIEW


1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC


2. NAME OF SCHEME:

GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001


3. PERIOD OF RETURN:

FROM: 21 JULY 2004 TO: 12 OCTOBER 2004


4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

N/A


5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

NIL

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

1,279,192 ORDINARY SHARES OF 0.1P EACH


7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004


PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.

110,965,581 ORDINARY SHARES OF 0.1P EACH




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BLRFXLFFZBBXFBK